Press Alt+1 for screen-reader mode, Alt+0 to cancelAccessibility Screen-Reader Guide, Feedback, and Issue Reporting | New window
timothy sykes logo

Stock News

BON Stock Rises: Is Now the Time?

Timothy SykesAvatar
Written by Timothy Sykes Reviewed by Jack Kellogg Fact-checked by Ellis Hobbs
Updated 5/20/2025, 9:18 am ET 5 min read
BON Stock Rises: Is Now the Time? Thumbnail

Bon Natural Life Limited stocks have been trading up by 10.77 percent, driven by promising market sentiment and strategic developments.

Recent Developments

  • BON Natural Life Limited signed a $32M deal with Beijing Huahai Keyuan to be its postbiotic hypoglycemic ingredients’ sales partner for three years, aiming for a strong presence in the global blood sugar market.

  • Introducing a sleep health series, BON uses an innovative delivery system addressing sleep-related compounds’ bio-activity, aiming to carve a market space.

  • On May 19, BON plans a 1-for-25 reverse stock split to comply with Nasdaq requirements, hoping to maintain its listing as stock interest distributions related to the stock remain unchanged.

Candlestick Chart

Live Update At 09:18:09 EST: On Tuesday, May 20, 2025 Bon Natural Life Limited stock [NASDAQ: BON] is trending up by 10.77%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Look at Recent Financials

In the world of trading, managing your risk is crucial to success. Many new traders get caught up in chasing profits and end up making decisions that lead to significant losses. Understanding when to walk away is an important skill. As millionaire penny stock trader and teacher Tim Sykes says, “It’s better to go home at zero than to go home in the red.” This philosophy emphasizes that preserving your trading capital is more important than aggressive tactics that could result in financial ruin. Successful traders learn to cut losses early and focus on strategies that provide steady growth over time.

Looking into BON’s recent earnings reports, the company shows a revenue of roughly $23.84M. However, its stock price to sales ratio sits at a low 0.11. Financial reports question its growth prospects, with total assets nearing $61.77M and a leverage ratio of 1.4 hinting towards a focus on balance sheet management. Market reactions are predictable given current updates.

Stock Movement Insights

BON’s stock price, interestingly, soared to $1.3 as of May 19, from $0.0638 a few days ago. Huge fluctuations likely follow news of the multi-million dollar deal with Beijing Huahai Keyuan. The company believes this strengthens its market shoes in blood sugar management products. The push in developing sleep-related goods demands attention as BON uses technology to solve existing bio-availability hurdles.

The stock’s movement also derives from the planned reverse stock split, an attempt to meet Nasdaq’s bid price requirements. One likely outcome is making stocks appeal more to investors. A three-year strategy with significant deals in place can keep the enthusiasm and drive future gains.

Market Perspective

New Agreement: Fresh Path in Hypoglycemia

Most intriguing, BON’s collaboration with Beijing Huahai Keyuan opens doors in the health sector, particularly in hypoglycemic product sales. With a staggering $32M deal, BON can delve into the lucrative market, targeting better global distribution.

More Breaking News

Sleep Health Innovations: A Market Game-Changer?

BON delved into sleep health products, capitalizing on innovations to uplift bio-activity aspects. This is pivotal, given sleep disorders’ escalating prevalence, which may secure significant market traction. This development complements its hypoglycemia-focused products, aligning parallel endeavors that foster company relevance in diverse medical niches.

What’s Next with Stock Performance?

Let’s dive deeper into some potential speculations within the industry. BON’s subtle positioning through strategic agreements and product diversifications could encourage a favorable market trend. An ongoing interest in its sleep health line could serve as a beacon for upcoming trading prospects.

Undoubtedly, the anticipated stock split and exclusive partnership highlight the visionary trajectory and attempts to bolster the brand’s position. However, achieving desired trader confidence demands intricate calibrations and logical alignments moving forward.

The fluctuating stock prices raise questions albeit with engaging opportunities, as showcased in the charts depicting marked oscillations lately. BON’s recent forays into cooperative ventures chart a promising yet cautious path ahead, meanwhile drawing enthusiasts into possible trading opportunities. As millionaire penny stock trader and teacher Tim Sykes, says, “There is always another play around the corner; don’t chase just because you feel FOMO.” This philosophy reminds traders to remain prudent and strategic in their moves, thus maintaining a balanced approach amid market flux.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Timothy Sykes

Tim Sykes is a penny stock trader and teacher who became a self-made millionaire by the age of 22 by trading $12,415 of bar mitzvah money. After becoming disenchanted with the hedge fund world, he established the Tim Sykes Trading Challenge to teach aspiring traders how to follow his trading strategies. He’s been featured in a variety of media outlets including CNN, Larry King, Steve Harvey, Forbes, Men’s Journal, and more. He’s also an active philanthropist and environmental activist, a co-founder of Karmagawa, and has donated millions of dollars to charity.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”

ts swipe photo
Join Thousands Profiting From Smart Trades!
TRADE LIKE TIM

We use cookies to provide you with the best online experience. If you continue browsing, we consider that you accept our Cookie Policy , and also agree to the terms of our Privacy Policy and Terms of Use.

notification icon
Subscribe to receive notifications